SCHEMBL13048601

SCHEMBL13048601

COc1ccc(Nc2nc(NC3CC3)c3c(S(C)(=O)=O)n[nH]c3n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 4/20 0.53
SYK P43405 6/20 0.48
MEN1 O00255 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
TYRO3 Q06418 4/20 0.44
AXL P30530 2/20 0.44
JAK2 O60674 1/20 0.44
JAK3 P52333 1/20 0.44
PTK2 Q05397 1/20 0.44
CTSL P07711 2/20 0.43
CTSS P25774 2/20 0.43
CTSK P43235 2/20 0.43
CTSB P07858 1/20 0.43
IGF1R P08069 1/20 0.41
FLT3 P36888 2/20 0.41
GAS6 Q14393 2/20 0.41
ULK1 O75385 1/20 0.40
ULK2 Q8IYT8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13048622 0.90 ULK1 (0.44) MERTKSYKMEN1BLMKMT2A
SCHEMBL13048598 0.89 SYK (0.52) MERTKSYKAXLFLT3
SCHEMBL13048626 0.88 SYK (0.45) MERTKSYKTYRO3JAK2JAK3
SCHEMBL13048126 0.87 ULK1 (0.53) MERTKSYKTYRO3AXLJAK2
SCHEMBL13048163 0.86 ADORA3 (0.50) SYKTYRO3JAK2JAK3PTK2
SCHEMBL13048365 0.86 SYK (0.51) MERTKSYKTYRO3JAK2JAK3
SCHEMBL13048161 0.86 SYK (0.54) SYKIGF1R
SCHEMBL13048621 0.85 SYK (0.48) SYKPTK2
SCHEMBL13048813 0.85 SYK (0.44) SYKMEN1KMT2AAURKA
SCHEMBL13048739 0.84 PTK2 (0.42) SYKJAK2JAK3PTK2IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298557-A1 PYRAZOLOPYRIMIDINE COMPOUND SYK, LCK, FYN MERTK 35/4885SYK 1/4885MEN1 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.